Related Experiment Video
Updated: Jan 26, 2026

Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs
Published on: June 12, 2018
BACE1-AS prevents BACE1 mRNA degradation through the sequestration of BACE1-targeting miRNAs
Tao Zeng1, Haitao Ni1, Yue Yu2
1Research Center of Developmental Biology, Second Military Medical University, Shanghai, 200433, China.
Abstract:
Abnormal long noncoding RNAs (lncRNAs) and microRNAs (miRNAs) participate in the pathophysiology of Alzheimer's disease (AD). However, it remains unclear whether these two types of noncoding RNAs functionally interact and which factors mediate these interactions in AD. β-secretase 1 (BACE1) is the enzyme responsible for amyloid plaque formation, which is a central pathological feature of AD. The lncRNA BACE1-AS and some miRNAs have been implicated in the regulation of BACE1. In this study, we reveal that BACE1-AS shares many miRNA-response elements with BACE1. The overexpression of BACE1-AS results in the repression of miRNAs that target BACE1, thus preventing BACE1 mRNA from being degraded. The knockdown of BACE1-AS increases the levels of these miRNAs, thereby reducing the expression of BACE1. Thus, BACE1-AS functions as a competing endogenous RNA (ceRNA). Our results also deepen the understanding of the regulation of BACE1 by BACE1-AS. In addition to increasing the stability of BACE1 mRNA through the formation of RNA duplexes, BACE1-AS can regulate BACE1 indirectly by acting as a ceRNA. Therefore, we propose that BACE1 functions as a ceRNA and forms a network through its associations with protein-coding genes, lncRNAs and miRNAs in the pathophysiology of AD.
Insights
Long noncoding RNA BACE1-AS acts as a competing RNA (ceRNA) in Alzheimer's disease (AD). It regulates beta-secretase 1 (BACE1) by sequestering microRNAs, impacting amyloid plaque formation in AD.
Area of Science:
- Molecular Biology
- Neuroscience
- Genetics
Background:
- Abnormal long noncoding RNAs (lncRNAs) and microRNAs (miRNAs) are implicated in Alzheimer's disease (AD) pathophysiology.
- The role of interactions between lncRNAs and miRNAs in AD pathogenesis is not fully understood.
- Beta-secretase 1 (BACE1), crucial for amyloid plaque formation in AD, is regulated by BACE1-AS and certain miRNAs.
Purpose of the Study:
- To investigate the functional interaction between BACE1-AS and miRNAs in the context of AD.
- To elucidate the mechanism by which BACE1-AS influences BACE1 expression.
- To explore the role of BACE1-AS as a competing endogenous RNA (ceRNA) in AD.
Main Methods:
- Analysis of miRNA-response elements shared between BACE1-AS and BACE1.
- Experimental manipulation of BACE1-AS levels (overexpression and knockdown).
- Assessment of miRNA levels and BACE1 mRNA degradation.
Main Results:
- BACE1-AS shares miRNA-response elements with BACE1.
- Overexpression of BACE1-AS represses miRNAs targeting BACE1, stabilizing BACE1 mRNA.
- Knockdown of BACE1-AS increases miRNA levels, reducing BACE1 expression, confirming BACE1-AS acts as a ceRNA.
Conclusions:
- BACE1-AS functions as a ceRNA, indirectly regulating BACE1 by sequestering miRNAs.
- BACE1-AS influences BACE1 stability through RNA duplex formation and ceRNA activity.
- BACE1 is proposed to be a ceRNA, forming a regulatory network with genes, lncRNAs, and miRNAs in AD pathophysiology.
More Related Videos
Related Concept Videos
Proteins: From Genes to Degradation
Transcription is the synthesis of RNA...
Nuclear Export of mRNA
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Regulated mRNA Transport

